ExcellGene is a Swiss Biologics-CDMO (Contract Development and Manufacturing Organization) specialized in the development and manufacturing of proteins for the pharmaceutical industry. The company's core activity encompasses providing services for the development and manufacturing of biologics, including: cell line development (CHO and HEK cells), genome engineering, cGMP cell banking, process development, ensuring clonality of existing cell lines, and biosimilars. The company supports pharmaceutical companies in the development and manufacturing of proteins for drug development, offering a combination of scientific expertise and technological infrastructure.